Number of Prescription adults diagnosed for ACE with LVSD or Number of adults DEC* DEC DEC inhibitor or HF and diagnosed with NA NA NA ROR: 0.57 ROR: 0.57 ROR: 0.86 ARB therapy prescribed ACE LVSD or HF [0.37-0.87] [0.30-1.07] [0.29-2.48] for LVSD or Q15 inhibitor or HF ARB therapy Number of adults diagnosed Persistence on with LVSD or ACE inhibitor Number of adults INC DEC DEC HF and or ARB diagnosed with NA NA NA ROR: 1.12 ROR: 0.89 ROR: 0.77 persistent with therapy for LVSD or HF [0.85-1.47] [0.64-1.24] [0.39-1.50] Q16 prescribed ACE LVSD or HF inhibitor or ARB therapy HEALTH SERVICES UTILIZATION MEASURES Number of INC DEC DEC DEC INC INC Proportion patients with Total number of ROR: 1.04 ROR: 0.92 ROR: 0.91 ROR: 0.99 ROR: 1.07 ROR: 1.03 U01 with ED visit one or more patients [0.94-1.13] [0.85-1.00] [0.84-0.99] [0.96-1.03] [1.00-1.15] [0.94-1.13] ED visits Number of patients Proportion of diagnosed with Number of asthma, CHF, DEC* DEC DEC* INC DEC INC* U02 asthma, CHF, or patients diagnosed or diabetes ROR: 0.89 ROR: 0.86 ROR: 0.81 ROR: 1.17 ROR: 0.98 ROR: 1.51 diabetes and with any of these patients with [0.82-0.96] [0.72-1.04] [0.70-0.94] [0.90-1.50] [0.70-1.35] [1.09-2.10] recording a conditions ED visit ED visit
Q15 Prescription for ACE inhibitor or ARB therapy for LVSD or HF Number of adults diagnosed with LVSD or HF and prescribed ACE inhibitor or ARB therapy Number of adults diagnosed with LVSD or HF DEC* ROR: 0.57 [0.37-0.87] DEC ROR: 0.57 [0.30-1.07] DEC ROR: 0.86 [0.29-2.48] NA NA NA Q16 Persistence on ACE inhibitor or ARB therapy for LVSD or HF Number of adults diagnosed with LVSD or HF and persistent with prescribed ACE inhibitor or ARB therapy Number of adults diagnosed with LVSD or HF INC ROR: 1.12 [0.85-1.47] DEC ROR: 0.89 [0.64-1.24] DEC ROR: 0.77 [0.39-1.50] NA NA NA HEALTH SERVICES UTILIZATION MEASURES U01 Proportion with ED visit Number of patients with one or more ED visits Total number of patients INC ROR: 1.04 [0.94-1.13] DEC ROR: 0.92 [0.85-1.00] DEC ROR: 0.91 [0.84-0.99] DEC ROR: 0.99 [0.96-1.03] INC ROR: 1.07 [1.00-1.15] INC ROR: 1.03 [0.94-1.13] U02 Proportion of asthma, CHF, or diabetes patients with ED visit Number of patients diagnosed with asthma, CHF, or diabetes and recording a ED visit Number of patients diagnosed with any of these conditions DEC* ROR: 0.89 [0.82-0.96] DEC ROR: 0.86 [0.72-1.04] DEC* ROR: 0.81 [0.70-0.94] INC ROR: 1.17 [0.90-1.50] DEC ROR: 0.98 [0.70-1.35] INC* ROR: 1.51 [1.09-2.10]
MLR_2018_01_18_HARRIS_MDC-D-17-00555R1_SDC1.docx